Lichen Amyloidosis Medication

Updated: Dec 09, 2020
  • Author: Sultan Al-Khenaizan, MBBS, FRCPC; Chief Editor: William D James, MD  more...
  • Print

Medication Summary

The goal of pharmacotherapy for lichen amyloidosis is to reduce morbidity.



Class Summary

These agents act by competitive inhibition of histamine at the H1 receptor. They may control itching by blocking effects of endogenously released histamine.

Chlorpheniramine (Chlor-Trimeton)

Chlorpheniramine competes with histamine or H1 receptor sites on effector cells in blood vessels and the respiratory tract.

Diphenhydramine (Benadryl)

Diphenhydramine is used for symptomatic relief of symptoms caused by the release of histamine in allergic reactions.


Topical anti-inflammatory agents

Class Summary

This agent is an industrial solvent.

Dimethyl sulfoxide (Rimso-50)

Dimethyl sulfoxide may help relieve symptoms. DMSO, an oxidation product of dimethyl sulfide, is an exceptional solvent possessing a number of commercial uses. This not an FDA-approved indication.